Inmune Bio, Inc.·4

Aug 27, 4:42 PM ET

Tesi Raymond Joseph 4

4 · Inmune Bio, Inc. · Filed Aug 27, 2021

Insider Transaction Report

Form 4
Period: 2021-08-25
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2021-08-25$3.91/sh+30,000$117,3001,524,433 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-08-2530,000270,000 total
    Exercise: $3.91Exp: 2029-11-24Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]These options were exercised in a cash transaction by the Reporting Person under Rule 16(b)(3). The options were granted to the Reporting Person under the Company's 2019 Stock Incentive Plan.

Documents

1 file
  • 4
    ownership.xmlPrimary